Merck (NYSE: MRK) announced that it has acquired, through a subsidiary, OncoEthix, a Swiss-based privately held biotechnology company specializing in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE